- Home
- ESPR vs CUB Comparison
ESPR vs CUB Comparison
Compare ESPR & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- CUB
- Stock Information
- Founded
- ESPR 2008
- CUB 2024
- Country
- ESPR United States
- CUB United States
- Employees
- ESPR N/A
- CUB N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- CUB
- Sector
- ESPR Health Care
- CUB
- Exchange
- ESPR Nasdaq
- CUB NYSE
- Market Cap
- ESPR 305.0M
- CUB 310.7M
- IPO Year
- ESPR 2013
- CUB 2024
- Fundamental
- Price
- ESPR $1.61
- CUB $10.24
- Analyst Decision
- ESPR Buy
- CUB
- Analyst Count
- ESPR 7
- CUB 0
- Target Price
- ESPR $6.36
- CUB N/A
- AVG Volume (30 Days)
- ESPR 4.2M
- CUB 28.2K
- Earning Date
- ESPR 03-04-2025
- CUB 01-01-0001
- Dividend Yield
- ESPR N/A
- CUB N/A
- EPS Growth
- ESPR N/A
- CUB N/A
- EPS
- ESPR N/A
- CUB N/A
- Revenue
- ESPR $332,314,000.00
- CUB N/A
- Revenue This Year
- ESPR $5.51
- CUB N/A
- Revenue Next Year
- ESPR $1.42
- CUB N/A
- P/E Ratio
- ESPR N/A
- CUB N/A
- Revenue Growth
- ESPR 185.66
- CUB N/A
- 52 Week Low
- ESPR $1.47
- CUB $9.96
- 52 Week High
- ESPR $3.94
- CUB $10.55
- Technical
- Relative Strength Index (RSI)
- ESPR 48.04
- CUB N/A
- Support Level
- ESPR $1.47
- CUB N/A
- Resistance Level
- ESPR $1.61
- CUB N/A
- Average True Range (ATR)
- ESPR 0.13
- CUB 0.00
- MACD
- ESPR 0.01
- CUB 0.00
- Stochastic Oscillator
- ESPR 51.28
- CUB 0.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.